Articles from Saratoga Technologies, L.L.C.
ROCKWALL, TX / ACCESS Newswire / June 27, 2026 / Saratoga Technologies, L.L.C., on February 16, 2026, unveiled Laserase™, an FDA-cleared 1927nm Thulium laser system. This platform combines micro-ablative and non-ablative treatments to address pigmentation disorders, photoaging, fine lines, wrinkles, acne scarring, uneven texture, sun damage, melasma, freckles, post-inflammatory hyperpigmentation (PIH), actinic keratosis, enlarged pores, skin laxity, and hair/scalp conditions. It is safe for all Fitzpatrick types (I-VI) with minimal PIH risk.
By Saratoga Technologies, L.L.C. · Via ACCESS Newswire · June 27, 2026